Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 11075
  • 11076
  • 11077
  • …
  • ›
  • »

2025-05-13

Ovid Therapeutics GAAP EPS of -$0.14 in-line, revenue of $0.13M beats by $0.1M

2025-05-13

Atossa Therapeutics GAAP EPS of -$0.05 beats by $0.01

2025-05-13

Affimed Announces Filing for the Opening of Insolvency Proceedings

2025-05-13

Xebra Brands Ltd: Xebra Brands Advances Commercialization Efforts with NF Skin

2025-05-13

Red Cloud Financial Services: Blue Sky Uranium Presents in Red Cloud′s Virtual Webinar Series

2025-05-13

Odyssey Marine Exploration Reports Q1 2025 Results, Regains Nasdaq Compliance, and Announces New Capital Infusion

2025-05-13

LightInTheBox Reports First Quarter 2025 Financial Results

2025-05-13

Minerva Neurosciences GAAP EPS of -$0.50

2025-05-13

Leap Therapeutics GAAP EPS of -$0.37

2025-05-13

Adaptimmune Therapeutics PLC: Adaptimmune Reports Q1 Financial Results and Provides Business Update

2025-05-13

Romios Gold Resources Inc.: Romios Announces Field Work and Lakehead University M.Sc. Research Project on the Kinkaid High grade Cu-Au-Ag Project, Nevada

2025-05-13

Adaptimmune GAAP EPS of -$0.03 beats by $0.11, revenue of $7.29M beats by $0.74M

  • «
  • ‹
  • …
  • 11075
  • 11076
  • 11077
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 15/Jul/2026 13:28:18
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies